Pay in 4 interest-free payments of $6.88 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
This rapid growth has positioned GLP-1 agonists as one of the most lucrative drug classes in history, with projections indicating a continued upward trajectory
The appetite suppression feels different
This shift in usage patterns suggests these drugs are no longer solely reserved for managing severe metabolic conditions but are becoming a broader tool in preventive strategies
Practical help in 4 modules Module 1 Webinar Now available On Demand Understanding the issues around the GLP-1 RA shortage Understanding the impact of the current GLP-1 RA shortage Making sense of the guidance published Identifying and prioritising those affected Practical resources to support clinicians Plus downloadable guides: Module 2 Webinar Now available On Demand Tackling the GLP-1 RA shortage in clinical practice: A consultation guide Applying national guidance in practice Promoting patient-centred discussion Identifying appropriate alternatives to GLP-1 RAs Working through practical case examples Plus downloadable guides: Module 3 Common patient scenarios Now available on demand Module 4 Webinar Where are we now
Strano A (2002)
Kt cu mm mn, thm thu nhanh
US$ 29.13
US$ 21.14
US$ 22.86
US$ 27.01
US$ 25.99
US$ 24.01
US$ 20.95
US$ 21.20
US$ 20.31
US$ 25.01
US$ 20.27
US$ 23.25
US$ 21.63
US$ 26.46
US$ 29.13
